The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1223
December 5, 2005
View Complete Issue         Table of Contents 2019 
Mometasone (Asmanex Twisthaler) for Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Mometasone (Asmanex Twisthaler) for Asthma
December 5, 2005 (Issue: 1223)
The FDA has approved marketing of the corticosteroid mometasone furoate in an orally inhaled dry powder formulation (Asmanex Twisthaler - Schering-Plough) for maintenance treatment of asthma in patients at least 12 years old. Mometasone is also...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Mometasone (Asmanex Twisthaler) for Asthma
Article code: 1223b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.